| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.00084 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.00065 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.00046 | 1 |